As of Nov 25
| -0.84 / -1.37%|
The 15 analysts offering 12-month price forecasts for AbbVie have a median target of 75.00, with a high estimate of 85.00 and a low estimate of 56.00. The median estimate represents a +24.40% increase from the last price of 60.29.
The current consensus among 17 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.